Effectiveness, safety, and methotrexate dose-tapering pattern over two years of treatment with adalimumab and ≥12 mg/week methotrexate for early rheumatoid arthritis: results of the HAWK postmarketing surveillance study in Japan

Yoshiya Tanaka,Tsuneyo Mimori,Hisashi Yamanaka,Naomi Sunaga,Kazuo Morita,Junko Kimura,Tsutomu Takeuchi

Effectiveness, safety, and methotrexate dose-tapering pattern over two years of treatment with adalimumab and ≥12 mg/week methotrexate for early rheumatoid arthritis: results of the HAWK postmarketing surveillance study in Japan

2019

Yoshiya Tanaka
Tsuneyo Mimori
Hisashi Yamanaka
Naomi Sunaga
Kazuo Morita
Junko Kimura
Tsutomu Takeuchi

AbstractObjectives: To investigate the long-term effectiveness, safety, and methotrexate (MTX) dose-tapering patterns in patients with rheumatoid arthritis (RA) receiving adalimumab plus high-dose ...

Keywords:

Physical therapy
Rheumatoid arthritis
Methotrexate
Diabetes mellitus
Internal medicine
Adalimumab
Tapering
Postmarketing surveillance
Medicine
in patient
early rheumatoid arthritis

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations